Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events.
Saved in:
| Title: | Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events. |
|---|---|
| Authors: | Meiring, S.1 (AUTHOR), Busch, C. B. E.1 (AUTHOR), van Baar, A. C. G.2 (AUTHOR) a.c.vanbaar@amsterdamumc.nl, Hemke, R.2 (AUTHOR), Holleman, F.3 (AUTHOR), Nieuwdorp, M.4 (AUTHOR), Bergman, J. J. G. H. M.1 (AUTHOR) |
| Source: | Cardiovascular Diabetology. 9/22/2022, Vol. 21 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14752840 |
|---|---|
| DOI: | 10.1186/s12933-022-01628-z |
